Open Nav

Aethlon Medical, Inc.

  • Jim Joyce, Aethlon Medical, Inc.

Investor Awareness

  • Date:Thursday, October 18
  • Time:3:15 PM - 3:30 PM
  • Room:Elizabethan D
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:At Aethlon Medical, we are a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
  • Company Website:www.aethlonmedical.com
  • Company HQ City:San Diego
  • Company HQ Country:United States
  • Company HQ State:California                  
  • Ticker:AEMD
  • Exchange:Nasdaq
  • CEO/Top Company Official:Jim Joyce
  • Main Therapeutic Focus:Medical Devices
  • Lead Product in Development :Hemopurifier
  • Development Phase of Primary Product:Other/Not Applicable
Speakers
Jim Joyce
Aethlon Medical, Inc.
Back